Literature DB >> 5124397

The role of cholesteryl 14-methylhexadecanoate in peptide elongation reactions.

J Hradec, Z Dusek, E Bermek, H Matthaei.   

Abstract

1. Peptide-elongation factors were purified from rat liver and human tonsils and the contents of cholesteryl 14-methylhexadecanoate were determined in fractions obtained during enzyme purification. The relative contents of this compound in purified enzyme preparations was several times higher than that in the crude starting material. Elongation factors from human tonsils contained a significantly larger quantity of the cholesteryl ester than enzyme from rat liver. 2. Transfer enzymes extracted with various organic solvents showed variable decreased activities in both binding and peptidization assay. The decrease of enzymic activity was proportional to the amount of cholesteryl 14-methylhexadecanoate extracted from a given enzymic preparation. In systems containing both extracted elongation factors the polyphenylalanine synthesis was limited by the residual activity of the less active transfer factor. 3. The original enzymic activity of extracted transferases was fully recovered by the addition of pure cholesteryl 14-methylhexadecanoate in quantities corresponding to those extracted. 4. Increase of the relative contents of this cholesteryl ester during enzyme purification, decrease of the enzymic activity after the extraction and its recovery by the addition of this compound indicates that the presence of this ester in elongation factors is essential for the normal function of these enzymes.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5124397      PMCID: PMC1177096          DOI: 10.1042/bj1230959

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  Elongation factors from human lymphatic tissue: Isolation and some properties.

Authors:  E Bermek; H Matthaei
Journal:  FEBS Lett       Date:  1970-09-24       Impact factor: 4.124

2.  RESOLUTION OF AMINOACYL-TRANSFERRING ENZYMES FROM RAT LIVER BY MOLECULAR SIEVE CHROMATOGRAPHY.

Authors:  E GASIOR; K MOLDAVE
Journal:  J Biol Chem       Date:  1965-08       Impact factor: 5.157

3.  Separation of three microbial amino acid polymerization factors.

Authors:  J Lucas-Lenard; F Lipmann
Journal:  Proc Natl Acad Sci U S A       Date:  1966-06       Impact factor: 11.205

4.  Mechanisms in protein synthesis. XII. Sites of action of showdomycin in a cell-free polyphenylalanine synthesizing system from human lymphatic tissue: ribosomes and elongation factor TF II.

Authors:  E Bermek; W Krämer; H Mönkemeyer; H Matthaei
Journal:  Biochem Biophys Res Commun       Date:  1970-09-30       Impact factor: 3.575

5.  On the mechanism of coded binding of aminoacyl-tRNA to ribosomes: number and properties of sites.

Authors:  D Swan; G Sander; E Bermek; W Krämer; T Kreuzer; C Arglebe; R Zöllner; K Eckert; H Mathaei
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1969

6.  Evidence for the role of aminoacyltransferase II in peptidyl transfer ribonucleic acid translocation.

Authors:  L Skogerson; K Moldave
Journal:  J Biol Chem       Date:  1968-10-25       Impact factor: 5.157

7.  Evidence for the enzymatic binding of aminoacyl transfer ribonucleic acid to rat liver ribosomes.

Authors:  F Ibuki; K Moldave
Journal:  J Biol Chem       Date:  1968-02-25       Impact factor: 5.157

8.  The function of 80 S ribosomal subunits and effects of some antibiotics.

Authors:  D Vazquez; E Battaner; R Neth; G Heller; R E Monro
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1969

9.  Effect of cholesteryl 14-methylhexadecanoate on the activity of some amino acid-transfer ribonucleic acid ligases from mammalian tissues.

Authors:  J Hradec; Z Dusek
Journal:  Biochem J       Date:  1969-12       Impact factor: 3.857

10.  A chromatographic method for the quantitative determination of cholesterol 14-methylhexadecanoate (carcinolipin) in biological materials.

Authors:  J Hradec
Journal:  J Chromatogr       Date:  1968-02-06
View more
  12 in total

1.  Decreased activity of peptide-elongation factors after treatment with cholesterol esterase.

Authors:  J Hradec; Z Tuhácková; Z Dusek
Journal:  Biochem J       Date:  1978-04-15       Impact factor: 3.857

2.  Role of phospholipids in the multiple forms of mammalian elongation factor 1.

Authors:  A B Legocki; B Redfield; C K Liu; H Weissbach
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205

3.  Multiple forms of elongation factor 1 from calf brain.

Authors:  H M Moon; B Redfield; S Millard; F Vane; H Weissbach
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

4.  Particulate aminoacyl-tRNA synthetases are retained on heparin bound to Sepharose.

Authors:  J Hradec; Z Dusek
Journal:  Mol Biol Rep       Date:  1980-12-31       Impact factor: 2.316

5.  All factors required for protein synthesis are retained on heparin bound to Sepharose.

Authors:  J Hradec; Z Dusek
Journal:  Biochem J       Date:  1978-04-15       Impact factor: 3.857

6.  Cholesteryl esters are bound by a peptide-initiation and a peptide-elongation factor.

Authors:  Z Tuhácková; J Hradec
Journal:  Biochem J       Date:  1980-10-15       Impact factor: 3.857

7.  Purification and some properties of a protein factor binding and deacylating initiator transfer ribonucleic acid.

Authors:  P Pohlreich; O Kríz; Z Tuhácková; Z Dusek; J Hradec
Journal:  Biochem J       Date:  1979-02-01       Impact factor: 3.857

8.  Influence of cholesteryl 14-methylhexadecanoate on some ribosomal functions required for peptide elongation.

Authors:  J Hradec; Z Dusek; O Mach
Journal:  Biochem J       Date:  1974-02       Impact factor: 3.857

9.  Specific hydrolysis of methionyl-tRNA Met f catalyzed by a purified peptide.

Authors:  J Hradec
Journal:  Nucleic Acids Res       Date:  1975-11       Impact factor: 16.971

10.  Protein synthesis in the liver of rats injected with cholesteryl 14-methylhexadecanoate.

Authors:  E Komárková; J Hradec
Journal:  Biochem J       Date:  1972-09       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.